The authors and contributors of Patent Docs wish their readers and families a Happy Holidays. Publication of Patent Docs will resume on December 26th.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Docs on Twitter
Recent Posts
- In the Wake of the Supreme Court's Amgen v. Sanofi decision: What’s Next for Biotechnology Claims?
- Patent Luminaries Try to Set Congress Straight on Drug Price Controls
- Baxalta Inc. v. Genentech, Inc. (Fed. Cir. 2023)
- Judge Newman Suspended for One Year by Federal Circuit
- FTC Announces Efforts to Police Pharmaceutical Companies' Patent Behavior
- Azurity Pharmaceuticals Inc. v. Alkem Laboratories Ltd. (Fed. Cir. 2023)
- ACI Passport to Proficiency on Essentials of Hatch-Waxman and BPCIA
- ACI Paragraph IV Disputes Master Symposium
- Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2023)
- Broad Files Reply Brief in Interference No. 106,115 Cross-Appeal
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Some Human Embryonic Stem Cells Are Once Again Patent-eligible in Europe | Main | Chisum Patent Academy Patent Law Seminar »
December 24, 2014
Comments
The comments to this entry are closed.
October 2023
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
Categories
- Best Mode (2)
- Biosimilars (243)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (275)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (98)
- Conferences & CLE's (2967)
- Court Report (507)
- Damages (37)
- Definiteness (25)
- District Court (216)
- Double Patenting (31)
- Enablement (51)
- Federal Circuit (985)
- Food and Drug Administration (104)
- Hatch-Waxman (90)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (26)
- Infringement - Literal or DOE (88)
- Injunction (33)
- International IP (295)
- Inventorship (17)
- Licensing (129)
- Media Commentary (70)
- Miscellaneous (162)
- News from Abroad (102)
- Novelty (71)
- Obviousness (221)
- Patent Exhaustion (3)
- Patent Legislation (309)
- Patent Litigation (216)
- Patent Office Rules & Procedures (815)
- Patent Profiles (104)
- Patent Prosecution (98)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (364)
- Patentable Subject Matter (637)
- Personalized Medicine (5)
- Post-Grant Proceedings (155)
- PTAB Report (9)
- Study/Report (6)
- Supreme Court (257)
- Tools (5)
- Trade Secrets (10)
- Utility (4)
- Venue (11)
- Written Description (86)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Very best wishes for the holiday season and for the new year from the UK.
Posted by: Paul Cole | December 26, 2014 at 05:51 PM